Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Healthcare/Pharmaceutical Asset Management Market [Wi-Fi RTLS, RFID (Tags - Active & Passive, Software), IR, Ultrasound, Equipment & Patient Tracking, Staff Safety, Temperature & Humidity Monitoring, Drug Counterfeit] - Global Forecast to 2017

Indswift today is a renowned name among lakhs of employees of railways, armed forces, police force & paramilitary organizations. With the help of our Institution division we are able to cater to smallest & biggest government dispensaries, hospitals and remote and rural areas in India.

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The Global Bioinformatics Market was valued at $2.9 billion in 2012 and is poised to reach $7.5 billion by 2017 at a CAGR of 20.9%. Bioinformatics Technologies are used in various pharmaceutical and biotechnology sectors to support their growth.

Medico Marketing involves promotion of pharmaceutical products. It facilitates to continuously update physicians, nurses and pharmacists regarding the safe and effective use of medicines. Medico marketing encompasses activities by medicos or organizations to actualize markets for pharmaceutical care.

This division of Ind Swift aspires to help those who cannot afford costly branded medicines. It is further divided into Agile, Maxcare and Health Care divisions which include a vast array of over 500 products from various therapeutic segments namely Antibiotic, Anti-Infectives, Anti-Cold, Nutraceuticals, Anti-Convulsants, Analgesics, Anti-Diarrhoeal, Anti-Allergics, Anti-Inflammatory and Anti-Ulcer Drugs, Hypolipidaemic Drugs, Anti Malarial, Enzyme, Expectorants, Antipsychotics & Anti-Depressants.

North America dominated the market in 2013 and will continue to drive and dominate it by 2018. However, the market share of this region will decrease to 34.5%, primarily due to the sequestration cuts announced in the U.S., which have resulted in lower investments from the government in research activities supporting proteomics. At the same time, Asia and Latin America are poised to grow at a CAGR of 17% to 22% in the forecast period; this growth is largely driven by the growing research base in these regions and the increasing pharmaceutical research related to drug discovery and drug development, and diagnostics product development activities in these regions.

North America dominated the market, with the U.S. accounting for a major market share. Asia is poised to grow at the highest CAGR during the forecast period. The large share of the North American market can be attributed to factors such as rising incidences of chronic diseases, expanding biotechnology and pharmaceutical industries, government support, and the launch of new products in the region.

[300 Pages Report] Sterilization Equipment Market categorizes the global market by Services (Onsite & Offsite), Product (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Consumables (Indicators, Detergents, Pouches) & End User (Hospitals, Pharmaceuticals) & by Geography

The global air monitoring equipment market by product, end user, component, technology and geography. The end user segments included in this report are government and academia, commercial and residential users, refining, and oil and gas industries, power plants, pharmaceutical industry, and other end users (chemical, food, metal, and mining industries). The product segments included in this report are indoor air quality monitors and outdoor air quality monitors. Each of these market segments is further divided into multiple product segments and subsegments. The indoor air quality monitors are categorized into indoor fixed monitors and indoor portable monitors. Similarly, the outdoor air quality monitors are categorized into AQM stations, dust & particulate monitors, outdoor fixed monitors, and outdoor portable monitors.

Our patent services provides patent filing, intellectual property in the areas of chemical, pharmaceutical, ethical and generic products

Our patent services provides patent filing, intellectual property in the areas of chemical, pharmaceutical, ethical and generic products

More than 300 scientists and researchers participating both in person and virtually agreed on a set of global research priorities.

To bring new therapies to market, pharmaceutical, biotechnology, and medical device companies engage contract research organizations (CROs) for their expertise in navigating the complex landscape of product development and regulatory pathway.